Comparison of GSK Biologicals' DTaP-IPV Candidate Vaccine to DTaP and IPV Separately Administered Vaccines in Terms of Immune Response and Safety
Clinical trial NCT00263692 · COMPLETED
Trial details
- NCT number
- NCT00263692
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2002-11-01
- Primary completion
- 2004-09-01
- Enrollment
- 401
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.